Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

STUDIES ON THE TOXICITY AND PHARMACOLOGY OF VITAMIN B6 (2-METHYL-3-HYDROXY-4,5-BIS-(HYDROXYMETHYL)-PYRIDINE)

KLAUS UNNA and JOSEPH GRESLIN
Journal of Pharmacology and Experimental Therapeutics December 1940, 70 (4) 400-407;
KLAUS UNNA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOSEPH GRESLIN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

1. The L.D. 50 of vitamin B6 hydrochloride in rats is 3.7 grams per kilogram following subcutaneous injection and 5.5 grams per kilogram following oral adminstration.

2. Doses above 1 gram per kilogram of vitamin B6 produce toxic manifestations in dogs, rabbits, and rats characterized by impairment of the coordination and tonic convulsions. The dose required to produce these symptoms is at least 1000 times greater than the therapeutic dose.

3. Daily administration of vitamin B6 over a period of 80 days to dogs (20 mgm. per kilogram) and rats (25 mgm. per rat) failed to produce any toxic manifestations or pathological changes of the organs. Rats receiving 2.5 mgm. daily were raised through three generations.

4. The urine of apparently healthy men and dogs contains less than 0.5 micrograms of vitamin B6 per cubic centimeter as determined by bioassay.

5. The metabolism, the circulatory and respiratory system, and isolated smooth muscle organs of normal animals are not influenced by vitamin B6.

Footnotes

    • Received August 3, 1940.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 70, Issue 4
1 Dec 1940
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
STUDIES ON THE TOXICITY AND PHARMACOLOGY OF VITAMIN B6 (2-METHYL-3-HYDROXY-4,5-BIS-(HYDROXYMETHYL)-PYRIDINE)
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

STUDIES ON THE TOXICITY AND PHARMACOLOGY OF VITAMIN B6 (2-METHYL-3-HYDROXY-4,5-BIS-(HYDROXYMETHYL)-PYRIDINE)

KLAUS UNNA and JOSEPH GRESLIN
Journal of Pharmacology and Experimental Therapeutics December 1, 1940, 70 (4) 400-407;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

STUDIES ON THE TOXICITY AND PHARMACOLOGY OF VITAMIN B6 (2-METHYL-3-HYDROXY-4,5-BIS-(HYDROXYMETHYL)-PYRIDINE)

KLAUS UNNA and JOSEPH GRESLIN
Journal of Pharmacology and Experimental Therapeutics December 1, 1940, 70 (4) 400-407;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Interaction of Diclofenac and Quinidine in Monkeys: Stimulation of Diclofenac Metabolism
  • Binding, Partial Agonism, and Potentiation of α1-Adrenergic Receptor Function by Benzodiazepines: A Potential Site of Allosteric Modulation
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics